Zafgen Stock Price (NASDAQ:ZFGN)

Add to My Stocks
$10.78 $0.17 (1.55%) ZFGN stock closing price Sep 21, 2018 (Closing)
Prev Close* : $10.95
Market Cap:
$396.76M
Day Low: $10.28
52 Week Low: $3.24
Open: $10.82
Volume: -
Day High: $10.94
52 Week High: $11.39
Dividend:
0.00

Latest Stock Market News

Latest Articles

Zafgen News - From Partners

Zafgen Announces Pricing of Offering of Common Stock   by Globe Newswire on Jun 28, 2018

ZFGN Stockcharts

View ZFGN PE ratio, PS ratio stocks charts and compare with peers.
ZFGN Chart
Note: Compare Zafgen stock price history with the index and industry peers.

Zafgen Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Zafgen Returns

ROE
(return on equity)

Zafgen Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

ZFGN Industry Peers

Company Price Change (%)
Savara Inc (SVRA)11.210.03 (0.27%)
Polarity Te Inc (PTE)21.651.16 (5.09%)
Nutraceutical International (NUTR)41.80 (0%)
Johnson & Johnson (JNJ)142.880.9 (0.63%)
Aveo Pharmaceuticals (AVEO)2.860.03 (1.04%)
Evofem Bioscncs (EVFM)3.750.12 (3.1%)
Boston Scientific (BSX)37.770.05 (0.13%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Zafgen Inc Stock News - Partner Headlines

Zafgen Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-52.02M-57.87M-74.28M-36.47M-14.02M
Total Operating Expense52.99M58.21M73.8M35.53M13.77M
View Zafgen income statement
balance sheet20172016201520142013
Total Assets105.51M131.62M189.1M117.51M38.13M
Total Liabilities27.29M9.89M19.99M13.07M2.91M
Shareholders Equity78.21M121.72M169.11M104.44M35.22M
View Zafgen balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.09M-5.49M6.72M3.15M-1.63M
Net Cash from (used by) Operating Activities-43.78M-51.97M-59.55M-28.24M-15M
Increase (Decrease) in Prop Plant And Equipment-0.05M-0.66M-0.59M-0.05M-0.01M
View Zafgen cash flow statement

Zafgen Stock Message Board

Zafgen stock price ended the last trading day at $10.78. Stock price or share price can be used to find the total market value of a company. Zafgen market cap stands at $396.76M as of Sep 21, 2018. Zafgen valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Zafgen stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 1,206,825 shares were traded with a closing stock price of $10.78 as of Sep 21, 2018, as can be seen from Zafgen stock quote. One can view Zafgen stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Zafgen stock dividend was 0.00 during the last quarter. Zafgen stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.